Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Washington University School of Medicine
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
BerGenBio ASA
Stanford University
Vector Vitale LLC
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Blue Note Therapeutics
Hospital Universitario San Ignacio
First Affiliated Hospital of Wenzhou Medical University
Chinese PLA General Hospital
Shenzhen BinDeBio Ltd.
Butler Hospital
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Novacea